Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: A randomised trial

1. Mateos, M.-V.
2. Oriol, A.
3. Martínez-López, J.
4. Gutiérrez, N.
5. Teruel, A.-I.
6. de Paz, R.
7. García-Laraña, J.
8. Bengoechea, E.
9. Martín, A.
10. Mediavilla, J.D.
11. Palomera, L.
12. de Arriba, F.
13. González, Y.
14. Hernández, J.-M.
15. Sureda, A.
16. Bello, J.-L.
17. Bargay, J.
18. Peñalver, F.-J.
19. Ribera, J.-M.
20. Martín-Mateos, M.-L.
21. García-Sanz, R.
22. Cibeira, M.-T.
23. Ramos, M.-L.M.
24. Vidriales, M.-B.
25. Paiva, B.
26. Montalbán, M.-A.
27. Lahuerta, J.-J.
28. Bladé, J.
29. Miguel, J.-F.S.
30. Mostrar todos los/as autores/as +